Next Quarterly Earnings
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
BioMarin is a US-based biopharmaceutical company dedicated to researching, developing, and commercializing innovative therapies for rare genetic diseases. The company focuses on delivering life-changing medicines to improve patient care globally. BioMarin develops groundbreaking therapies.
After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
BioMarin is scheduled to report its next quarterly earnings on 11/03/2026. After-hours — typically from around 10:00 p.m. German time (after the US close at 4:00 p.m. New York time).
BioMarin last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at 1.20 USD.
Across its last 3 earnings reports, BioMarin stock moved by ±2% on average the following day. The largest reaction was -4% on 05/04/2026; 1 of 3 reactions were positive.
BioMarin has beaten analyst EPS estimates in 2 of its last 3 evaluated quarters (beat rate: 66.7%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: price reactions to the last 3 report dates (close to close).
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.